2025-12-15
September 2024 — $30M seed at $150M valuation August 2025 — $70M A at $550M valuation December 2025 — $130M B at $1.3B valuation Talking about scaling laws — AI startup Chai Discovery keeps on a furious fundraising pace w/ its latest round: https://endpoints.news/...
Bloomberg
AI drug discovery startup Chai Discovery raised a $130M Series B led by Oak HC/FT and General Catalyst at a $1.3B valuation, taking its total funding to $225M
Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules.
2025-11-17
Prometheus' co-CEO/co-founder is Vik Bajaj, most recently the CEO of Foresite Labs, where he helped co-found Xaira Therapeutics among other biotech efforts @CadeMetz has the scoop on Bezos' new startup with $6.2bn in funding: https://www.nytimes.com/...
New York Times
Sources: AI startup Project Prometheus raised $6.2B, including from Jeff Bezos, who is its co-CEO, his first operational role since leaving Amazon in July 2021
Called Project Prometheus, the company is focusing on artificial intelligence for the engineering and manufacturing of computers, automobiles and spacecraft.
2025-10-26
“The number one problem with all of AI drug discovery is they do not produce the code to make their molecule,” Lee Cronin told me. “Chemify is coming to the rescue for everybody.” https://endpoints.news/...
Chemical & Engineering News
Glasgow-based Chemify, which combines AI with robotics and chemistry to rapidly make novel molecules for pharmaceutical companies, raised a $50M+ Series B
Alex Scott / Chemical & Engineering News :
2024-10-19
Terray Therapeutics has raised a $120M Series B, aiming to get its lead drug into the clinic in 2026, CEO Jacob Berlin told me exclusively. How this LA area biotech has developed its own hardware in microarray chips to fuel its AI ambitions: https://endpts.com/...
SiliconANGLE
Terray Therapeutics, which uses AI to accelerate small-molecule drug development, raised a $120M Series B led by Bedford Ridge Capital and Nvidia's NVentures
Kyt Dotson / SiliconANGLE :
2024-04-24
BREAKING: With over $1 billion & a star-studded cast, a new AI bio called Xaira Therapeutics is launching with massive ambitions to remake R&D, its leaders exclusively tell @RLCscienceboss and me. A lot to unpack in this scoop — read it only @endpts: https://endpts.com/...
Bloomberg
Xaira Therapeutics, which aims to use AI models to find new drugs to treat diseases, emerged from stealth with $1B in commitments from Sequoia and others
read it only @endpts: https://endpts.com/... LinkedIn: Xaira Therapeutics : Incubated by ARCH Venture Partners and Foresite Labs, Xaira Therapeutics is on a mission to drive advanc...
2024-01-08
“They're not pilot projects. They're real drug targets,” @demishassabis told me. “We want to do things that ultimately, if successful, are really meaningful, actually cure diseases and lead to blockbuster drugs, rather than just pilots and sort of academic work.”
TechCrunch
DeepMind spinout Isomorphic Labs partners with Eli Lilly and Novartis on AI-based drug discovery, with $82.5M paid upfront and $2.9B in performance incentives
2021-10-06
Don't miss @dodgeblake's latest report, getting inside Apple and its health biz struggles Apple's culture held back its healthcare ambitions, as employees say it punishes people with concerns and leads people to misrepresent progress https://www.businessinsider.com/ ...
MacRumors
Report claims Apple's health team has faced several internal issues and high-level departures; Apple says the report is based on “inaccurate” information
Apple CEO Tim Cook has previously stated that Apple's greatest contribution to mankind will be related to health … Source: Insider .